As the CEO of UME Tech, Osokina’s forward-thinking innovations have empowered businesses to grow and achieve their goals.

Firefly Neuroscience (AIFF) announced the advancement of research to assess a patient’s brain age, an estimation of the biological age of a person’s brain, via its FDA-cleared BNA technology platform.

Researchers have developed a model explaining how place cells in the hippocampus anchor both spatial and episodic memories.

Pregnancy leads to a 4.9% reduction in gray matter volume in 94% of the brain, with partial recovery postpartum, primarily in ...

For leaders, understanding the neuroscience of conversation offers practical strategies for unlocking team potential.

Greg Lipschitz, Executive Chairman of Firefly, said, “This breakthrough underscores our commitment to pushing the boundaries of innovation in brain health, ultimately with the aim of making a ...

Firefly Neuroscience shares doubled to $3.90 Tuesday after the company said it is advancing its research used to assess a patient's brain age--an estimation of the biological age of a person's ...

As neuro-AI research advances, it holds the potential to revolutionize our understanding of intelligence by seamlessly ...

Maital Neta, professor of psychology at the University of Nebraska-Lincoln, is among U.S. scientists and engineers receiving ...

The work was led by Ian Maze, a neuroepigeneticist at the Icahn School of Medicine at Mount Sinai and Howard Hughes Medical Institute who published the initial paper showing that serotonin could ...

Firefly Neuroscience, Inc. ("Firefly" or the "Company") (NASDAQ: AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that ...

Get Real-Time News and Alerts for Your Portfolio Firefly Neuroscience, Inc. AIFF shares are trading ... has been successfully ...